Evaluation of the safety and tolerability of FB2001 after a single and multiple dose administrations in healthy subjects;Pharmacokinetic parameter (AUC0-τ);Pharmacokinetic parameter (Cmax)

Evaluation of the safety and tolerability of FB2001 after a single and multiple dose administrations in healthy subjects;Pharmacokinetic parameter (AUC0-τ);Pharmacokinetic parameter (Cmax)

The incidence of adverse events（AE） and adverse reactions（ADR）;The incidence of grade 3-4 adverse events and adverse reactions;The incidence of serious adverse events (SAE).

The incidence of adverse events（AE） and adverse reactions（ADR）;The incidence of grade 3-4 adverse events and adverse reactions;The incidence of serious adverse events (SAE).